TY - JOUR
T1 - PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER
AU - Mandelli, Laura
AU - Mazza, Marianna
AU - Marangoni, Ciro
AU - Di Nicola, Marco
AU - Martinotti, Giovanni
AU - Tavian, Daniela
AU - Colombo, Elisa
AU - Missaglia, Sara
AU - Negri, Gloria
AU - De Ronchi, Diana
AU - Colombo, Roberto
AU - Janiri, Luigi
AU - Serretti, Alessandro
PY - 2011
Y1 - 2011
N2 - Objective: Genes involved in inflammation, oxidative stress and calcium signaling may be involved in Bipolar disorder (BD). Comorbidity for substance use disorders (SUD) is frequent in BD, and shared genetic mechanics may be hypothesized. In the present study we preliminarily investigated polymorphisms within Interleukin 1-beta (IL1b), neuronal Nitric oxide adaptor protein (NOS1AP) and Transient receptor potential cation channel 2 (TRPM2) in BD and comorbidity for SUD. Method: One-hundred and thirty-one (131) BD patients (66 comorbid for SUD) and 64 healthy controls were genotyped for rs1143634, rs1143627, rs16944, rs1143623 (IL1b), rs12742393 (NOS1AP) and rs1556314 (TRPM2). Results: Genetic variants were not found associated to BD, while rs1143627 and a haplotype in IL1b showed significant associations with SUD, both comparing SUD subjects with healthy controls and to non-comorbid BD patients. Conclusions: The present study has several limitations, mainly linked to the small sample size and the naturalistic characterization of the study design. Taking into account these limitations and the preliminary nature of the study, present data do not support a role of IL1b, NOS1AP and TRPM2 in BD, though ILb1 may play a role in SUD.
AB - Objective: Genes involved in inflammation, oxidative stress and calcium signaling may be involved in Bipolar disorder (BD). Comorbidity for substance use disorders (SUD) is frequent in BD, and shared genetic mechanics may be hypothesized. In the present study we preliminarily investigated polymorphisms within Interleukin 1-beta (IL1b), neuronal Nitric oxide adaptor protein (NOS1AP) and Transient receptor potential cation channel 2 (TRPM2) in BD and comorbidity for SUD. Method: One-hundred and thirty-one (131) BD patients (66 comorbid for SUD) and 64 healthy controls were genotyped for rs1143634, rs1143627, rs16944, rs1143623 (IL1b), rs12742393 (NOS1AP) and rs1556314 (TRPM2). Results: Genetic variants were not found associated to BD, while rs1143627 and a haplotype in IL1b showed significant associations with SUD, both comparing SUD subjects with healthy controls and to non-comorbid BD patients. Conclusions: The present study has several limitations, mainly linked to the small sample size and the naturalistic characterization of the study design. Taking into account these limitations and the preliminary nature of the study, present data do not support a role of IL1b, NOS1AP and TRPM2 in BD, though ILb1 may play a role in SUD.
KW - IL1b
KW - NOS1AP
KW - TRPM2
KW - bipolar depression
KW - gene
KW - substance-related disorders
KW - IL1b
KW - NOS1AP
KW - TRPM2
KW - bipolar depression
KW - gene
KW - substance-related disorders
UR - http://hdl.handle.net/10807/8741
M3 - Article
SN - 1724-4935
SP - 347
EP - 353
JO - Clinical Neuropsychiatry
JF - Clinical Neuropsychiatry
ER -